B1243 Vol-1Œ25 Cumulative Index.Qxd

B1243 Vol-1Œ25 Cumulative Index.Qxd

b1243_ Vol-1 25_Cumulative Index.qxd 9/13/2012 11:02 AM Page 1 FA Cumulative Index to Volumes 1–25* A esters, IV: 8–10, IV: 366 1-Acyldipyrromethanes, XXIII: 112 formation statistical cis-AB porphyrin from two C5-pathway to, XV: 164–165, non-identical, XXIII: 101 XV: 170–175 trans-A2B2 magnesium porphyrin from, Shemin pathway to, XV: 164–170 XXIII: 101 leishmaniasis treatment by ALA or Metvix 1-Azidohexadecanethiol, XXI: 29 (ALA methyl ester), IV: 285 2,3-Anthraporphyrins, II:32, II:38 peptide derivatives, IV: 9–10 2-Arylaminoporphyrins, Buchwald–Hartwig as photodynamic therapy (PDT) agent, reaction and, II:241 IV: 7–8, IV: 285 2-Aza-21-carbaporphyrin. See N-confused structure, IV: 329 porphyrin (NCP) synthetic peptide conjugates, IV: 348–349 2-Aza-5,10,15,20-tetraphenyl-21- transport out of mitochondria of, carbaporphyrin, II:106, II: 107 XV: 10–11 2-Azabenziporphyrin, synthesis and metalation undecyl 5-aminolevulinate (Und-ALA), of, XVI: 192 IV: 366 3,4-Alkylenedioxypyrroles, XVII: 264 5-(4-Aminophenyl)-10,15,20-triphenylporphyrin 3-Acetyl-bacteriochlorins (semisynthetic Ag(II), Cu(II), Ni(II), Zn(II), and Pd(II) chlorophylls), XI: 263–265 complexes’ microwave-assisted 3-Aminotriazole (3-AT), IV: 413 synthesis of, II: 199–200 3-Azabenziporphyrin, synthesis and Fe(III) and Mn(III) complexes’ microwave- protonation of, XVI: 194 assisted synthesis of, II: 200 5-Alkenyl-15-alkynyl–porphyrin, XXIII: 97 17-Allylamino-17-methoxygeldanamycin 5-Aminolevulinic acid (ALA), XX: 7, (17-AAG), IV: 439–440 XX: 219, XX: 221 [18]Annulene, II: 173 adenosine and thymidine conjugates, 22-Acetoxydimethoxybenziporphyrins, proton IV: 10, IV: 12 NMR chemical shifts for, XVI: 117 ALA-based photosensitizers, IV: 7–11, 22-Acetoxy-m-benziporphyrin, II: 145 IV: 12 22-Acetoxytetraphenylbenziporphyrin, ALA derivatives as multifunctional agents, hydrolysis and metalation of, XVI: 149 IV: 10 22-Alkylbenzocarbaporphyrins, with conversion into iron-PPIX, XV: 5 palladium(II) acetate, metalation of, conversion into uroporphyrinogen III XVI: 48 (Urogen), XX: 220 α-Adenosyl-cobalamin, XXV: 148 dendritic ALA, IV: 369–371 α-Cyanodiazo reagents, XXI: 216 * Volume numbers are given in Roman numerals followed by a colon and precede the relevant pages. 1 b1243_ Vol-1 25_Cumulative Index.qxd 9/13/2012 11:02 AM Page 2 FA 2 Cumulative Index to Volumes 1–25 α-Free dipyrromethane, XXI: 116 conjugated porphyrin arrays and, I: 4 α-Functionalized isoindoles, synthesis of corrphycenes and, VII: 383, VII: 390–392 TBPs and Pcs and, II: 6 equine hemoproteins and, VII: 157–160 α-Phycoerythrocyanin (α-PEC), XXII: 4, 16 and film on cuvette walls for BChl mimics, phycoviolobilin (PVB) chromophore in, I: 259–262 Φ XXII: 5 fluorescence spectra/quantum yields ( F) A1B3-porphyrin, XXIII: 37 and, VII: 281–282 A2B2-porphyrin, XXIII free-base starting from mono-α-protected pyrrole, porphycenes VII: 380–390 XXIII: 100 porphyrin electronic spectras and Qx/Qy A3B1-porphyrin, XXIII: 37 notation, VII: 380–381 A3 porphyrins from mixed dipyrromethane fused structures and, I: 78–79, I: 81–82 condensation, XXIII: 99 future outlook of charge transfers and, I: 208 A4-porphyrin, XXIII: 37 hemiporphycenes and, VII: 383, AB and AB2 porphyrins, synthesis of, VII: 390–392 XXIII: 126 ionic pyrene derivatives and SWNT, AB3-type phthalocyanine, preparation, I: 201–202 XVIII: 246 isoporphycene derivatives and, ABC mitochondrial erythroid (ABC-me), and VII: 390–392 transport of PPIX to FECH, XV: 15 maxima. See Electronic absorption ABCB6 maxima and FECH interaction with PPIX oxidase, metal-bridged porphyrin arrays and, I: 110, XV: 95–96 I: 112 and transport of CPgenIII into/PPgenIX metallotetrapyrrole-fullerene dyads and, within mitochondria, XV: 12–13 I: 313 ABCB7, and transport of PPIX to FECH, of methyl 3-substituted pyropheophorbides, XV: 15 XI: 243–244 ABCB10, XV: 97–98 nanometer scale structures and, I: 136 and transport of PPIX to FECH, XV: 15 non-covalently linked hybrids (MP/C60 ABCD-porphyrin, XXIII: 59 β-systems) and, I: 183–184 via bilanes, route to, XXIII: 114 non-covalently linked hybrids (ZnP Absolute configurations, of natural products via functions) and, I: 179 conformational analysis, VII: 232–239 and optical properties (summary) of Absorption. See also Infrared spectroscopy/ porphyrinoids, XIV: 480–481 microscopy; Spectroscopic data inter- perimeter model for absorption elucidation, pretation; Photophysical properties of VII: 392–397 expanded porphyrins; Photophysical π-skeletal effect in organic solvents and, properties of porphyrin arrays XI: 229–230 chlorophylls and, XI: 226 photophysical processes after light of chlorophyll/bacteriochlorophyll/chlorin/ absorption and Jablonski diagram, bacteriochlorin systems, VII: 179–181 VII: 268 of chlorophyll hetero-dyads, VII: 196–197 and photophysical properties of aromatic and chlorosomal bacteriochlorophylls, rings with increasing numbers of I: 229–230 π electrons, XIV: 485–486, circular dichroism (CD)/electronic XIV: 485–486 absorption spectra and hemoglobin, porphyrinoids and origin of intensity of, VII: 154–156 XIV: 476–477 b1243_ Vol-1 25_Cumulative Index.qxd 9/13/2012 11:02 AM Page 3 FA Cumulative Index to Volumes 1–25 3 predicted absorption spectra based on Acid-acetone method, and removal of heme TD-DFT/ZINDO/s methods, from heme pocket, V: 7 XIV: 514–515 Acid-alcohol pair sequential, cytochrome P450 prototropic tautomer detection, XIV: 483–485 enzymes and, V: 185–186 radiative/nonradiative rates for Acidic reaction porphycenes and derivatives, and preparation of 3,6-bis(trifluoromethyl)- VII: 401, VII: 403 phthalonitrile, III: 72, III: 76 spectra of butadiyne-linked porphyrin trialkylsilyl-substituted phthalocyanines dimer, I: 4, I: 7 and, III: 45 and SWNT functionalized with PMMA Acid-labile metalloporphyrin, synthesis of, dendrimers, I: 195 I: 49 synthetic heme systems and, VII: 165–171 Acidobacteria, I: 223, XX: 108 and transmetalation of Mg to Zn in Acridine, IV: 3, IV: 23, IV: 409, IV: 410 bacteriochlorophyll a, XI: 234 AcsF (aerobic cyclization system for toluene solutions, VII: 403 Fe-containing subunit), XX: 13–14, UV-vis-IR absorption spectra of porphyrins XX: 117 and meso-meso-linked porphyrin Actinide derivatives, metalloporphyrin arrays, XIV: 483 derivatives, XXIV: 125–126 Abzymes, FECH mimetics/distortion and, Actinide elements absorption spectra, IX: 37–39 XV: 84 Activatable photosensitizer conjugates, Acenaphtho[1,2-b]porphyrins (AcePs), II: 48 IV: 281–284, IV: 285–286 Acenaphthoporphyrins, properties of, XIII: Activator protein 1 (AP-1), IV: 430 10–11 Active oxygen. See Compound I Acetonitrile (ACN) Active targeting, IV: 330, IV: 332–354 electropolymerization and, XII: 246 antimicrobial PDT, IV: 388–389 nickel porphyrins in alkaline solution and, avidin-biotin complex (AB-C), IV: 330–331 XII: 265 dendrimers, IV: 331 poly(Co(II)-31) films and, XII: 258–259 modular carrier systems, IV: 36, Acetylamino-substituted phthalocyanines, IV: 330–331, IV: 341, IV: 374 examples of, III: 115–118 multiplying units in antibody conjugates, Acetylcholinesterases (AChEs), and enzyme IV: 330–331, IV: 335, IV: 342, inhibition-based biosensors, V: 218 IV: 369, IV: 374 Acetylene-linked contracted porphyrinoids, photoimmunotherapy, overview, IV: 330, synthesis of, XVI: 312 IV: 332–333 Acetylene photosensitizer conjugates for active bonds, ethynyl-conjugated porphyrin arrays targeting, overview, IV: 355–362 and, I: 6 polyphasic tumor targeting (PTT), derivative/N-fused porphyrin coupling, IV: 330–331 Sonogashira C–C coupling reactions See also Cellular targeting; Monoclonal and, III: 344 antibodies (MAb); Passive targeting; Acetylenic crown ether-appended zinc specific conjugate types porphyrin, XXIV: 241 Acute intermittent porphyria (AIP), XV: 183 Acetylenic porphyrins, Sonogashira C–C Acyclic coupling reactions and, III: 341–342 anion receptors, VIII: 167–168. See also Acetylenyl bridged porphyrins, access to Pyrrole-based π-conjugated acyclic highly conjugated, XXIII: 238 anion receptors b1243_ Vol-1 25_Cumulative Index.qxd 9/13/2012 11:02 AM Page 4 FA 4 Cumulative Index to Volumes 1–25 zinc porphyrin dimer, supramolecular Adenosyl-imidazolyl-cobamide, XXV: 139 polymerization of, I: 52 Adenosyltransferases, XXV: 206–208 Acyclic dipyrromethane, XXIII: 14 CobA from S. enterica, mechanism and Acyl carrier protein (ACP), XIX: 83 crystal structure of, XXV: 45 complex formed between P450(BioI) PduO-type adenosyltransferase, XXV: 206 and, XIX: 84 structure of, XXV: 207 Acyl-CoA-mutases, XXV: 183–187 adj-Diazuliporphyrins ethylmalonyl-CoA mutase (ECM), metalation of, XVI: 266 XXV: 186–187 synthesis and protonation of, XVI: 264 isobutyryl-CoA mutase (ICM), XXV: 187 crystal structure of, II: 169 methylmalonyl-CoA-mutase (MCM), adj-Dicarbaporphyrin, XVI: 246 XXV: 183–186 coordinated complexes of, II: 167–168, Acylation with excess of reagents, XXIII: 116 II: 169 Adaptability, antenna pigments and, XI: 7 adj-Dicarbaporphyrinoids, XVI: 252–275 Adeninyl-3-propyl-cobalamin, XXV: 148 systems, retrosynthetic analysis of, XVI: 255 Adeninylcobamides, XXV: 139 Adler–Longo method, XXIII: 86 Adenosine diphosphate (ADP), nanoparticles Adler–Longo–Lindsey methods, XXIII: 87 and, XII: 366 Adler-type reactions Adenosine phosphosulfate (APS), XIX: 143 Adler-Longo porphyrin synthesis Adenosine triphosphate (ATP), nanoparticles procedure, III: 432–433 and, XII: 366 and combinatorial chemistry of porphyrins, Adenosylcobalamin, XXV: 69 III: 493–498 synthesis of, XXV: 69 six-member libraries using two different Adenosylcobamides, XXV: 234–235 aldehydes, III: 525–529 Adenosylcob(III)yric

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    324 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us